Efficacy of leeching (Ta‘līq al-‘Alaq) in patients with vitiligo (baras): a comprehensive case study

Authors

  • Arsheed Iqbal Regional Research Institute of Unani Medicine, CCRUM Srinagar, Jammu and Kashmir, India
  • Adil Rashid Regional Research Institute of Unani Medicine, CCRUM Srinagar, Jammu and Kashmir, India
  • Afroza Jan Regional Research Institute of Unani Medicine, CCRUM Srinagar, Jammu and Kashmir, India
  • Haider . Regional Research Institute of Unani Medicine, CCRUM Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20213371

Keywords:

Vitiligo, Unanai medicine, Melanocytes, Hirudotherapy, Leeching

Abstract

Vitiligo is a hypomelanotic skin disorder in white patches appear on the skin surface and also involve the hair. The disease is idiopathic, acquired and effects 1-4 percent of the world population. It is belived that there is immunologic influence in the pathogenesis of vitiligo and there is evidence of early cell death in vitiligo melanocytes related to their increased sensitivity to oxidative stress. In Ayurveda the vitiation of three doshas results deraignment of rasa, rakta, mamsa and medadhuta which results in vitiligo patches on skin. In Unani System of Medicine (USM) the deraignment of body humours result in the Fasad-e-Ikhlat which results in the Baras (vitiligo). Since both in Ayurveda and USM leech has been used for various dermatalogicalailments including vitiligo. In this study leeching (hirudotherapy) were done in vitiligo patients of both sexes with single and multiple patches and successful results were observed.

Metrics

Metrics Loading ...

References

Lerner AB. Vitiligo. Journal of Invest Dermatology. 1959;32:285-310. http://dx.doi.org/10.1038/jid.1959.49

Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important? JAMA. 1978;239:1183-7.

Bolognia JL, Pawelek JM. Biology of hypo pigmentation. Journal of American Academy of Dermatology. 1988;19:217-55.

Valia AK, Dutta PK. IADVL Text book and Atlas of Dermatology. Bhalani Publishing House: Mumbai. 1996;500.

Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol Internet. 2018;51(10):1206-12.

Sams WM, Lynch PJ. Principles and practice of dermatology Internet. Churchill Livingstone; 1990.

Christopher G, Barker J, Bleiker T, Robert C, Creamer D. Rook‟s Textbook of Dermatology Internet. 9th editio. Wiley-Blackwell. 2016.

Standard Unani Treatment Guidelines for Common Diseases. New Delhi: Central Council For Research in Unani Medicine. 2014;180-2.

Ali MI, Khan MMA, Shakera AR. Seminar on Bars (Leucoderma) 10th - 11th March, 1979, Hyderabad. In Hyderabad: Central Council For Research in Unani Medicine. 1979;6.

Rāzī ABM, Ibn Z. Kitab al-Hawif‟ilTibb (Arabic version). Hyderabad: DairatulMarif, Osmania University. 1970;23:72-5.

Ḥasan TA, Bin M. Al-Muālajat al-Buqrāṭiya (Vol-II). New Delhi: Central Council For Research in Unani Medicine. 1997;199-200.

Jurjāni AH. DhakhīraKhawārizmShāhī. Khan HHH, editor. New Delhi: IdaraKitab-us-Shifa, 2075, Kucha Chelan, Darya Ganj. 2010;8:18.

Gāzrūnī S al-D. Al-Sadīdī (Arabic). Lucknow: MaṭbaMunshiNawalKishor. 61-62.

Rāzī ABM, Ibn Z. Kitāb al-Mansūri (Urdu translation). New Delhi: Central Council For Research in Unani Medicine. 1991;207.

Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. "Vitiligo". Lancet. 2015;386(9988):74-84.

Whitton ME, Ashcroft DM, González U. Therapeutic interventions for vitiligoJ".o urnal of the American Academy of Dermatology. 2018;59(4):713-7.

Anon Vitilgo treatment. Patient UK. NHS. Available at: https://web.archive.org/web/20130606020140/ http://www.nhs.uk/Conditions/Vitiligo/Pages/Treatment.aspx). Accessed on 03 June 2013.

Lamkanfi M, VandeWalle L, Kanneganti TD. Deregulated inflammasomesignaling in disease. Immunol Rev (Review). 2011;243(1):163-73.

Gregersen PK. Modern genetics, ancient defenses, and potential therapiesT". New England Journal of Medicine. 2011;356(12):1263-6.

Jin Y, Mailloux CM, GowanK. "NALP1 in vitiligo-associated multiple autoimmune disease"T. N Engl J Med. 2007;356(12):1216-25.

National Institute of Arthritis and Musculoskeletal and Skin Diseases. What Is Vitiligo? Fast Facts: AnEasy-to-Read Series of Publications for the Public. Available at: http://www.niams.nih.gov/Health_Info/ Vitiligo/vitiligo_ff.asp#c). Accessed on 18 July 2010.

Wolff K, Freedberg IM, Fitzpatrick TB. Fitzpatrick's dermatology in general medicine (7th ed.). New York: McGraw-Hill Professional.

Halder RM, Chappell JL. Vitiligo update". Seminars in Cutaneous Medicine and Surgery. 2009;28(2):86-92.

Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, et al. Interventions for vitiligo. The Cochrane Database of Systematic Review. 2015;2:CD003263.

Downloads

Published

2021-08-24

How to Cite

Iqbal, A., Rashid, A., Jan, A., & ., H. (2021). Efficacy of leeching (Ta‘līq al-‘Alaq) in patients with vitiligo (baras): a comprehensive case study. International Journal of Basic & Clinical Pharmacology, 10(9), 1143–1148. https://doi.org/10.18203/2319-2003.ijbcp20213371

Issue

Section

Case Series